Medtronic plc

NYSE:MDT Lagerbericht

Marktkapitalisierung: US$104.7b

Medtronic Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Medtronic wird ein jährliches Gewinn- und Umsatzwachstum von 12.9% bzw. 4.3% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 13.9% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 15.4% betragen.

Wichtige Informationen

12.8%

Wachstumsrate der Gewinne

13.8%

EPS-Wachstumsrate

Medical Equipment Gewinnwachstum16.6%
Wachstumsrate der Einnahmen4.4%
Zukünftige Eigenkapitalrendite15.4%
Analystenabdeckung

Good

Zuletzt aktualisiert12 Jun 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts

Feb 22
Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts

Recent updates

Medtronic: Why I Disagree With The Crowd

Jun 14

Medtronic's (NYSE:MDT) Upcoming Dividend Will Be Larger Than Last Year's

Jun 10
Medtronic's (NYSE:MDT) Upcoming Dividend Will Be Larger Than Last Year's

Medtronic: Net Income Could Fall $3.38B, The Stock Would Still Be Undervalued

May 27

Medtronic (NYSE:MDT) Has Announced That It Will Be Increasing Its Dividend To $0.70

May 26
Medtronic (NYSE:MDT) Has Announced That It Will Be Increasing Its Dividend To $0.70

These 4 Measures Indicate That Medtronic (NYSE:MDT) Is Using Debt Reasonably Well

May 22
These 4 Measures Indicate That Medtronic (NYSE:MDT) Is Using Debt Reasonably Well

Medtronic Stock Looks Promising Before Fiscal Q4 2024 Release

May 13

Is Medtronic plc (NYSE:MDT) Trading At A 20% Discount?

May 01
Is Medtronic plc (NYSE:MDT) Trading At A 20% Discount?

35% Undervalued? Medtronic's Future Looks Very Bright

Apr 12

Medtronic: Buy This Dividend Aristocrat Diamond In The Rough Now

Mar 27

Medtronic: Undervalued Medical Devices Stock With Robust Demand And Strong Dividend Growth

Mar 11

Medtronic (NYSE:MDT) Has Announced A Dividend Of $0.69

Mar 11
Medtronic (NYSE:MDT) Has Announced A Dividend Of $0.69

Medtronic: Its Recent Beat Proves That It Continues To Be A Rock

Feb 25

Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts

Feb 22
Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts

Medtronic: A Good Choice For Dividend Investors Seeking For Low Volatility

Feb 16

A Look At The Fair Value Of Medtronic plc (NYSE:MDT)

Jan 31
A Look At The Fair Value Of Medtronic plc (NYSE:MDT)

Does Medtronic (NYSE:MDT) Have A Healthy Balance Sheet?

Jan 16
Does Medtronic (NYSE:MDT) Have A Healthy Balance Sheet?

Medtronic Stock's Rally Is Set To Continue

Jan 11

Medtronic plc's (NYSE:MDT) Price Is Out Of Tune With Earnings

Dec 29
Medtronic plc's (NYSE:MDT) Price Is Out Of Tune With Earnings

Medtronic's (NYSE:MDT) Dividend Will Be $0.69

Dec 12
Medtronic's (NYSE:MDT) Dividend Will Be $0.69

Medtronic: The GLP-1 Drug Headwinds Are Overblown

Dec 10

3.5% Yield And Over 15% Annual Return Potential - I Really Like Medtronic

Nov 28

Returns On Capital At Medtronic (NYSE:MDT) Have Hit The Brakes

Nov 19
Returns On Capital At Medtronic (NYSE:MDT) Have Hit The Brakes

Medtronic: 3 Key Issues To Consider Ahead Of Fiscal Q2 2024 Earnings

Nov 17

Medtronic Faces Potential Decline Despite Financial Strength

Oct 29

An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 21% Undervalued

Oct 19
An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 21% Undervalued

Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly

Oct 04
Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly

Medtronic: Improved Guidance, Historically Cheap P/E, Yield Reaches 3.5%

Sep 27

Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69

Sep 18
Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69

Medtronic: The Tide Is Turning

Aug 24

Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69

Aug 21
Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69

Medtronic: Dark Clouds Are Clearing - Outperformance Ahead

Aug 14

Return Trends At Medtronic (NYSE:MDT) Aren't Appealing

Aug 11
Return Trends At Medtronic (NYSE:MDT) Aren't Appealing

Medtronic: Expanding Product Portfolio Without Affecting Dividend Growth

Jul 15

Are Medtronic plc (NYSE:MDT) Investors Paying Above The Intrinsic Value?

Jul 09
Are Medtronic plc (NYSE:MDT) Investors Paying Above The Intrinsic Value?

Is Medtronic (NYSE:MDT) A Risky Investment?

Jun 21
Is Medtronic (NYSE:MDT) A Risky Investment?

Medtronic: Weak Forecasts Spoiled Strong Results For The Reporting Quarter

Jun 21

Is Medtronic's Dividend In A Good Place?

Jun 14

Medtronic (NYSE:MDT) Is Increasing Its Dividend To $0.69

Jun 03
Medtronic (NYSE:MDT) Is Increasing Its Dividend To $0.69

Medtronic: Solid Q4 Earnings, Don't Fret About Guidance

May 26

Gewinn- und Umsatzwachstumsprognosen

NYSE:MDT - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
4/30/202736,7515,9776,9248,96119
4/30/202635,0255,7256,7518,62831
4/30/202533,4175,0166,3747,97930
4/26/202432,3643,6765,2006,787N/A
1/26/202432,3204,2014,9316,470N/A
10/27/202331,9584,1024,0455,570N/A
7/28/202331,5583,6204,4445,831N/A
4/28/202331,2273,7584,5806,039N/A
1/27/202330,7714,0644,1665,636N/A
10/28/202230,8064,3214,8226,290N/A
7/29/202231,0705,2055,7217,137N/A
4/29/202231,6865,0395,9787,346N/A
1/28/202231,7854,9145,6787,034N/A
10/29/202131,7984,7045,7737,162N/A
7/30/202131,5973,8825,8557,254N/A
4/30/202130,1173,6064,8856,240N/A
1/29/202127,9262,8924,6315,945N/A
10/30/202027,8683,5374,7525,996N/A
7/31/202027,9274,4124,7566,002N/A
4/24/202028,9134,7896,0217,234N/A
1/24/202031,0625,4086,6597,871N/A
10/25/201930,8914,7626,2987,519N/A
7/26/201930,6664,4205,6716,815N/A
4/26/201930,5574,6315,8737,007N/A
1/25/201930,5554,8264,8675,958N/A
10/26/201830,3782,1684,8645,905N/A
7/27/201829,9473,1634,5685,649N/A
4/27/201829,9533,1043,6164,684N/A
1/26/201829,7252,859N/A5,419N/A
10/27/201729,6395,069N/A5,502N/A
7/28/201729,9344,115N/A6,067N/A
4/28/201729,7104,028N/A6,880N/A
1/27/201729,3613,968N/A6,433N/A
10/28/201629,0124,242N/A6,145N/A
7/29/201628,7253,647N/A5,952N/A
4/29/201628,8333,538N/A5,218N/A
1/29/201628,4352,434N/A5,804N/A
10/30/201525,8192,316N/A5,774N/A
7/31/201523,1272,624N/A5,408N/A
4/24/201520,2612,675N/A4,902N/A
1/23/201517,4103,124N/A4,318N/A
10/24/201417,2552,909N/A4,163N/A
7/25/201417,0832,983N/A4,286N/A
4/25/201416,8933,065N/A4,959N/A
1/24/201416,8793,586N/A4,901N/A
10/25/201316,7433,812N/A4,735N/A
7/26/201316,6443,556N/A4,593N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: MDTDas prognostizierte Gewinnwachstum (12.9% pro Jahr) liegt über der Sparquote (2.4%).

Ertrag vs. Markt: MDTDie Erträge des Unternehmens (12.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (14.8% pro Jahr).

Hohe Wachstumserträge: MDTDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: MDTDie Einnahmen des Unternehmens (4.3% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.7% pro Jahr).

Hohe Wachstumseinnahmen: MDTDie Einnahmen des Unternehmens (4.3% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: MDTDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (15.4%).

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y